DE3686365T2 - Herstellungsverfahren fuer humanes atriales natriuretisches polypeptid. - Google Patents
Herstellungsverfahren fuer humanes atriales natriuretisches polypeptid.Info
- Publication number
- DE3686365T2 DE3686365T2 DE8686304723T DE3686365T DE3686365T2 DE 3686365 T2 DE3686365 T2 DE 3686365T2 DE 8686304723 T DE8686304723 T DE 8686304723T DE 3686365 T DE3686365 T DE 3686365T DE 3686365 T2 DE3686365 T2 DE 3686365T2
- Authority
- DE
- Germany
- Prior art keywords
- hanp
- fused
- protective peptide
- peptide
- human atrial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/32—Fusion polypeptide fusions with soluble part of a cell surface receptor, "decoy receptors"
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB858515686A GB8515686D0 (en) | 1985-06-20 | 1985-06-20 | Production of-human atrial natriuretic polypeptide |
GB868600754A GB8600754D0 (en) | 1986-01-14 | 1986-01-14 | Human atrial natriuretic polypeptide |
Publications (3)
Publication Number | Publication Date |
---|---|
DE3686365D1 DE3686365D1 (de) | 1992-09-17 |
DE3686365T2 true DE3686365T2 (de) | 1993-01-14 |
DE3686365T3 DE3686365T3 (de) | 2000-07-27 |
Family
ID=26289399
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3686365T Expired - Fee Related DE3686365T3 (de) | 1985-06-20 | 1986-06-19 | Herstellungsverfahren für humanes atriales natriuretisches Polypeptid. |
Country Status (5)
Country | Link |
---|---|
US (2) | US6403336B1 (de) |
EP (2) | EP0440311A1 (de) |
JP (1) | JPH0633316B2 (de) |
AT (1) | ATE79409T1 (de) |
DE (1) | DE3686365T3 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3686365T3 (de) | 1985-06-20 | 2000-07-27 | Fujisawa Pharmaceutical Co | Herstellungsverfahren für humanes atriales natriuretisches Polypeptid. |
US5340725A (en) * | 1986-10-09 | 1994-08-23 | Fujisawa Pharmaceutical Co., Ltd. | Expression vector for insulin-like growth factor I and method of production |
EP0264074B1 (de) * | 1986-10-09 | 1992-12-30 | Fujisawa Pharmaceutical Co., Ltd. | Expressionsvektor für menschlichen insulinähnlichen Wachstumsfaktor-I |
DK175535B1 (da) * | 1987-03-04 | 2004-11-29 | Daiichi Suntory Pharma Co Ltd | Fremgangsmåde til fremstilling af et fysiologisk aktivt cysteinholdigt peptid |
US7049102B1 (en) | 1989-09-22 | 2006-05-23 | Board Of Trustees Of Leland Stanford University | Multi-gene expression profile |
AUPN283195A0 (en) * | 1995-05-05 | 1995-06-01 | Australian Water Technologies Pty Ltd | Method for the detection of viable cryptosporidium parvum cells |
DE19535445A1 (de) * | 1995-09-23 | 1997-03-27 | Boehringer Mannheim Gmbh | Verfahren zur Herstellung von natriuretischen Peptiden über Streptavidin-Fusionsproteine |
EP1281759B1 (de) * | 2000-05-10 | 2009-07-08 | Asubio Pharma Co., Ltd. | Verfahren zur hemmung der bildung von nebenprodukten bei der herstellung von genetisch modifizierten polypeptiden |
US7357124B2 (en) * | 2002-05-10 | 2008-04-15 | Philip Morris Usa Inc. | Multiple capillary fuel injector for an internal combustion engine |
US7459290B1 (en) | 2004-03-30 | 2008-12-02 | Iowa State University Research Foundation, Inc. | Methods of using functional 30S subunits |
US7337768B2 (en) * | 2004-05-07 | 2008-03-04 | Philip Morris Usa Inc. | Multiple capillary fuel injector for an internal combustion engine |
EP1951277A2 (de) * | 2005-10-14 | 2008-08-06 | Biorexis Pharmaceutical Corporation | Mit natriuretischem peptid modifizierte transferrin-fusionsproteine |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE871782A (fr) * | 1977-11-08 | 1979-05-07 | Genentech Inc | Procede permettant l'expression microbienne de polypeptides et moyens appropries |
NL7811042A (nl) * | 1977-11-08 | 1979-05-10 | Genentech Inc | Werkwijze en middel voor het tot uitdrukking brengen van microbieel polypeptide. |
IE53166B1 (en) * | 1980-08-05 | 1988-08-03 | Searle & Co | Synthetic urogastrone gene,corresponding plasmid recombinants,transformed cells,production thereof and urogastrone expression |
EP0116784B1 (de) * | 1982-02-22 | 1992-06-10 | Queen's University At Kingston | Atrial natriuretischer Faktor |
GB8314362D0 (en) | 1983-05-24 | 1983-06-29 | Celltech Ltd | Polypeptide and protein products |
US4617149A (en) * | 1983-09-21 | 1986-10-14 | Eli Lilly And Company | Growth hormone release factor analogs |
US4703004A (en) * | 1984-01-24 | 1987-10-27 | Immunex Corporation | Synthesis of protein with an identification peptide |
US4952561A (en) * | 1984-02-07 | 1990-08-28 | Merck & Co., Inc. | Cardiac atrial peptides |
DK108685A (da) * | 1984-03-19 | 1985-09-20 | Fujisawa Pharmaceutical Co | Vaekstfaktor i |
US4745179A (en) * | 1984-04-02 | 1988-05-17 | Fujisawa Pharmaceutical Co., Ltd. | 59 Valine insulin-like growth factor I and process for production thereof |
US4851349A (en) * | 1984-04-12 | 1989-07-25 | Mitsubishi Chemical Industries Limited | Expression vectors encoding cardionatrin and cardiodilatin |
EP0180615B1 (de) * | 1984-04-19 | 1995-04-05 | Scios Nova Inc. | Atrielle natriumuretische/gefässerweiterende polypeptide |
AU600652B2 (en) * | 1984-06-08 | 1990-08-23 | Hisayuki Matsuo | Human atrial natriuretic peptide and gene encoding same |
CA1340625C (en) * | 1984-06-29 | 1999-07-06 | Peter L. Davies | Cloned cardionatrin cdna |
EP0221923A4 (de) * | 1985-03-29 | 1990-03-22 | Bioteknika International | Sekretionsvektor. |
WO1986006742A1 (en) * | 1985-05-07 | 1986-11-20 | California Biotechnology Inc. | Fused proteine for enzyme immunoassay system |
EP0207044A1 (de) * | 1985-06-20 | 1986-12-30 | Monsanto Company | Freisetzung von Peptiden aus Polypeptiden |
DE3686365T3 (de) | 1985-06-20 | 2000-07-27 | Fujisawa Pharmaceutical Co | Herstellungsverfahren für humanes atriales natriuretisches Polypeptid. |
JPS62135500A (ja) * | 1985-06-20 | 1987-06-18 | モンサント コンパニ− | ポリペプチドからのペプチドの放出 |
GB8518753D0 (en) * | 1985-07-24 | 1985-08-29 | Glaxo Group Ltd | Microbiological products |
DK175535B1 (da) * | 1987-03-04 | 2004-11-29 | Daiichi Suntory Pharma Co Ltd | Fremgangsmåde til fremstilling af et fysiologisk aktivt cysteinholdigt peptid |
-
1986
- 1986-06-19 DE DE3686365T patent/DE3686365T3/de not_active Expired - Fee Related
- 1986-06-19 EP EP91200595A patent/EP0440311A1/de not_active Withdrawn
- 1986-06-19 EP EP86304723A patent/EP0206769B2/de not_active Expired - Lifetime
- 1986-06-19 AT AT86304723T patent/ATE79409T1/de not_active IP Right Cessation
-
1992
- 1992-10-16 JP JP4278583A patent/JPH0633316B2/ja not_active Expired - Fee Related
-
1995
- 1995-01-09 US US08/370,356 patent/US6403336B1/en not_active Expired - Fee Related
-
2002
- 2002-10-24 US US10/279,061 patent/US20030170811A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20030170811A1 (en) | 2003-09-11 |
JPH0633316B2 (ja) | 1994-05-02 |
EP0440311A1 (de) | 1991-08-07 |
ATE79409T1 (de) | 1992-08-15 |
US6403336B1 (en) | 2002-06-11 |
JPH067187A (ja) | 1994-01-18 |
EP0206769B2 (de) | 1999-11-10 |
DE3686365D1 (de) | 1992-09-17 |
EP0206769A3 (en) | 1988-12-28 |
EP0206769A2 (de) | 1986-12-30 |
DE3686365T3 (de) | 2000-07-27 |
EP0206769B1 (de) | 1992-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0238023A3 (en) | Process for the production of protein products in aspergillus oryzae and a promoter for use in aspergillus | |
EP0150126A3 (en) | The synthesis of protein with an identification peptide | |
NO174351C (no) | Fremgangsmåte for fremstilling av human insulinforlöper samt DNA-sekvens og vektor til anvendelse av fremgangsmåten | |
IE883612L (en) | Vectors and compounds for direct expression of activated human protein c | |
ES2000278A6 (es) | Procedimiento para preparar una proteina de fusion y para preparar una proteina eucariotica. | |
DE3686365D1 (de) | Herstellungsverfahren fuer humanes atriales natriuretisches polypeptid. | |
EP0722461A4 (de) | Expression eines fusionspolypeptides, das ohne leadersequenz aus dem cytoplasma transportiert wird | |
CZ738982A3 (en) | Human immune interferon and derivative thereof, separated dna with sequence encoding human immune interferon, recombinant cloning vector, replicable expression vector, recombinant micro-organism or cellular culture, pharmaceutical preparation, process for preparing the human immune interferon and its use | |
ES8604252A1 (es) | Un metodo para recuperar una hormona de credimiento de un animal purificada | |
CA2089094A1 (en) | Expression of recombinant polypeptides with improved purification | |
EP0824148A3 (de) | Polyester-Synthase Gen und Verfahren zur Herstellung von Polyestern | |
NZ510385A (en) | E. coli enterotoxin II signal peptide and a microorganism expressing a fusion protein of the MST peptide and a heterologous protein, such as human growth hormone | |
ZA8860B (en) | Pancreatic secretory trypsin inhibitor and variants thereof produced by a recombinant host,process,expression vector and recombinant host therefor and pharmaceutical use thereof | |
WO1996017941A3 (en) | Production of c-terminal amidated peptides from recombinant protein constructs | |
KR970065558A (ko) | 분비형 Kex2 유도체의 제조방법 | |
DE3479734D1 (en) | Novel, physiologically active polypeptides and production method thereof | |
EP0306673B1 (de) | Verfahren zur Herstellung von menschlichem Wachstumshormon | |
EP0195680A3 (de) | Proteinsynthese mit einem Identifizierungspeptid | |
DK0387646T3 (da) | Achromobacter-protease I-gen og genprodukt deraf | |
KR940007182A (ko) | 재조합 인간 알파 인터페론 발현벡터, 균주 및 이를 이용한 인간 알파 인터페론의 제조방법 | |
EP0750040A3 (de) | Varianten des Makrophagen-stimulierendes-Proteins und Verfahren zur ihrer Herstellung | |
RU92004585A (ru) | Промотор, днк-последовательность, вектор, клетки, способ экспрессии днк | |
EP0197558A3 (de) | Verfahren zur Herstellung von Somatostatin | |
RU93032287A (ru) | Способ получения окситоцина и рекомбинантные плазмидные днк ptoteilox и штаммы escherichia coli tg1/ptoteilox для его осуществления | |
GB1210557A (en) | Synthesis of polypeptides containing cysteine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent | ||
8366 | Restricted maintained after opposition proceedings | ||
8339 | Ceased/non-payment of the annual fee |